Maharashtra-based manufacturer of Fine, Specialty and Performance Chemicals, Amines & Surfactants, and APIs serving pharma, agrochemical, fertilizer and petrochemical industries
Price
Market Cap
Sector
Commodities
Rank
| Line item | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 33 | 35 | 35 | 35 | 36 | 36 | 36 | 36 |
| Reserves | 102 | 127 | 152 | 190 | 228 | 281 | 324 | 356 |
| Borrowings | 143 | 159 | 207 | 232 | 217 | 284 | 307 | 311 |
| Other Liabilities | 83 | 131 | 160 | 140 | 153 | 177 | 176 | 194 |
| Total Liabilities | 362 | 453 | 554 | 597 | 635 | 779 | 843 | 897 |
| AssetsFixed Assets | 117 | 125 | 182 | 198 | 209 | 265 | 268 | 325 |
| CWIP | 24 | 54 | 22 | 20 | 23 | 35 | 65 | 31 |
| Investments | 0 | 0 | 0 | 0 | 2 | 3 | 3 | 3 |
| Other Assets | 221 | 274 | 350 | 379 | 401 | 476 | 507 | 539 |
| Total Assets | 362 | 453 | 554 | 597 | 635 | 779 | 843 | 897 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 27 | 39 | 56 | 15 | 20 | 70 | 35 | 79 |
| Cash from Investing | -43 | -36 | -50 | -39 | -30 | -27 | -82 | -71 |
| Cash from Financing | 17 | -3 | -1 | 32 | 4 | -41 | 42 | -1 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | -16 | 2 | 6 | -24 | -10 | 44 | -48 | 7 |
| FCF Margin | — | — | — | — | — | — | — | — |
The Earnings Per Share over the last 12 months.
Your assumption of the company's expected yearly EPS growth (e.g., 6 for 6%).
Pre-filled with the lower of median (17.6×) and current (15.7×) PE — the conservative anchor.
The annualized return you aim to achieve. We solve for the price that delivers it, then compare to today's price.
At 18.8% growth and a 16× exit, ₹144 only delivers your return if you pay ₹155. The price is currently baking in 17% growth.
EPS grows 18.8%/yr for 5 years, then fades to 6% over 2, exits at 16×.
| Year | Growth | EPS (₹) |
|---|---|---|
| FY27 | 18.8% | 10.87 |
| FY28 | 18.8% | 12.91 |
| FY29 | 18.8% | 15.34 |
| FY30 | 18.8% | 18.23 |
| FY31 | 18.8% | 21.65 |
| FY32 | 12.4% ·fade | 24.34 |
| FY33 | 6.0% ·fade | 25.80 |
Methodology: we discount normalized net profit as a proxy for owner earnings (an earnings-power approximation — not full free cash flow). Terminal growth is capped at 6% (≈ nominal GDP) regardless of the required return. This is an analytical tool, not investment advice.
Guides on how to read this kind of business and the numbers that matter.